Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
Mansing Ratanasukon, Koblarp Thongthong, Patama Bhurayanontachai, Pichai JirarattanasopaDepartment of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Hat yai, Songkhla Province, ThailandBackground: To evaluate photoreceptor disruption in patients with central serous chorioretinopat...
Saved in:
Main Authors: | Ratanasukon M, Thongthong K, Bhurayanontachai P, Jirarattanasopa P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/ec3b1c3cfe3c4fdd8d2340eb9d5cffd1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
by: Sanguansak T, et al.
Published: (2015) -
Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
by: Fujita K, et al.
Published: (2012) -
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
by: Alkin Z, et al.
Published: (2014) -
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
by: Yu-Chen Hu, et al.
Published: (2021) -
Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
by: Tsakonas GD, et al.
Published: (2012)